SELLAS Life Sciences
SLS
SLS
44 hedge funds and large institutions have $15.4M invested in SELLAS Life Sciences in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
47% more funds holding
Funds holding: 30 → 44 (+14)
6.92% more ownership
Funds ownership: 8.8% → 15.73% (+6.9%)
Holders
44
Holding in Top 10
–
Calls
$3.33M
Puts
$40K
Top Buyers
| 1 | +$6.9M | |
| 2 | +$744K | |
| 3 | +$590K | |
| 4 |
BlackRock
New York
|
+$102K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$93.9K |
Top Sellers
| 1 | -$147K | |
| 2 | -$70.8K | |
| 3 | -$55.6K | |
| 4 |
Goldman Sachs
New York
|
-$16.3K |
| 5 |
RS
R Squared
Central,
Hong Kong
|
-$2.29K |
